769 related articles for article (PubMed ID: 17627615)
1. Pathogenesis and mechanism of disease progression from hemophagocytic lymphohistiocytosis to Epstein-Barr virus-associated T-cell lymphoma: nuclear factor-kappa B pathway as a potential therapeutic target.
Chuang HC; Lay JD; Hsieh WC; Su IJ
Cancer Sci; 2007 Sep; 98(9):1281-7. PubMed ID: 17627615
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus (EBV) latent membrane protein-1 down-regulates tumor necrosis factor-alpha (TNF-alpha) receptor-1 and confers resistance to TNF-alpha-induced apoptosis in T cells: implication for the progression to T-cell lymphoma in EBV-associated hemophagocytic syndrome.
Chuang HC; Lay JD; Chuang SE; Hsieh WC; Chang Y; Su IJ
Am J Pathol; 2007 May; 170(5):1607-17. PubMed ID: 17456766
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of tumor necrosis factor-alpha gene by Epstein-Barr virus and activation of macrophages in Epstein-Barr virus-infected T cells in the pathogenesis of hemophagocytic syndrome.
Lay JD; Tsao CJ; Chen JY; Kadin ME; Su IJ
J Clin Invest; 1997 Oct; 100(8):1969-79. PubMed ID: 9329960
[TBL] [Abstract][Full Text] [Related]
4. Microbiological findings and treatment of EBV-associated hemophagocytic lymphohistiocytosis: a case report.
Przybylski M; Dzieciatkowski T; Zduńczyk D; Jedrzejczak WW; Luczak M
Arch Immunol Ther Exp (Warsz); 2010 Jun; 58(3):247-52. PubMed ID: 20383798
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of cloned expansion and CD5 down-regulation in Epstein-Barr Virus (EBV)-infected CD8+ T lymphocytes in EBV-associated hemophagocytic lymphohistiocytosis.
Toga A; Wada T; Sakakibara Y; Mase S; Araki R; Tone Y; Toma T; Kurokawa T; Yanagisawa R; Tamura K; Nishida N; Taneichi H; Kanegane H; Yachie A
J Infect Dis; 2010 Jun; 201(12):1923-32. PubMed ID: 20443735
[TBL] [Abstract][Full Text] [Related]
6. [Clinical features and outcome analysis of 83 childhood Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis with HLH-2004 protocol].
Xiao L; Xian Y; Dai BT; Su YC; Xiao JW; Zheng QC; Zhao XD; Yu J
Zhonghua Xue Ye Xue Za Zhi; 2011 Oct; 32(10):668-72. PubMed ID: 22339824
[TBL] [Abstract][Full Text] [Related]
7. Selective efficacy of depsipeptide in a xenograft model of Epstein-Barr virus-positive lymphoproliferative disorder.
Roychowdhury S; Baiocchi RA; Vourganti S; Bhatt D; Blaser BW; Freud AG; Chou J; Chen CS; Xiao JJ; Parthun M; Chan KK; Eisenbeis CF; Ferketich AK; Grever MR; Chen CS; Caligiuri MA
J Natl Cancer Inst; 2004 Oct; 96(19):1447-57. PubMed ID: 15467034
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus LMP1 inhibits the expression of SAP gene and upregulates Th1 cytokines in the pathogenesis of hemophagocytic syndrome.
Chuang HC; Lay JD; Hsieh WC; Wang HC; Chang Y; Chuang SE; Su IJ
Blood; 2005 Nov; 106(9):3090-6. PubMed ID: 16002423
[TBL] [Abstract][Full Text] [Related]
9. Infection of T lymphocytes in Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children of non-Asian origin.
Beutel K; Gross-Wieltsch U; Wiesel T; Stadt UZ; Janka G; Wagner HJ
Pediatr Blood Cancer; 2009 Aug; 53(2):184-90. PubMed ID: 19353621
[TBL] [Abstract][Full Text] [Related]
10. Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan.
Sato E; Ohga S; Kuroda H; Yoshiba F; Nishimura M; Nagasawa M; Inoue M; Kawa K
Am J Hematol; 2008 Sep; 83(9):721-7. PubMed ID: 18626884
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of apoptosis in Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
Kawada J; Kimura H; Shibata Y; Hara S; Hoshino Y; Kojima S; Nishikawa K; Morishima T
J Med Virol; 2006 Mar; 78(3):400-7. PubMed ID: 16419109
[TBL] [Abstract][Full Text] [Related]
12. Immunophenotypic analysis of Epstein-Barr virus (EBV)-infected CD8(+) T cells in a patient with EBV-associated hemophagocytic lymphohistiocytosis.
Wada T; Kurokawa T; Toma T; Shibata F; Tone Y; Hashida Y; Kaya H; Yoshida T; Yachie A
Eur J Haematol; 2007 Jul; 79(1):72-5. PubMed ID: 17532761
[TBL] [Abstract][Full Text] [Related]
13. [Five adult cases of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis].
Abe Y; Shiratsuchi M; Nagasawa E; Ohtsuka R; Kiyasu J; Sada E; Idutsu K; Kotoh K; Nishimura J; Ohga S; Takayanagi R
Rinsho Ketsueki; 2010 Jan; 51(1):74-9. PubMed ID: 20134144
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus-associated T-/natural killer cell lymphoproliferative diseases.
Yachie A; Kanegane H; Kasahara Y
Semin Hematol; 2003 Apr; 40(2):124-32. PubMed ID: 12704589
[TBL] [Abstract][Full Text] [Related]
15. Hemophagocytic syndromes and infection.
Fisman DN
Emerg Infect Dis; 2000; 6(6):601-8. PubMed ID: 11076718
[TBL] [Abstract][Full Text] [Related]
16. NF-kappaB inhibitors induce lytic cytotoxicity in Epstein-Barr virus-positive nasopharyngeal carcinoma cells.
Liu SF; Wang H; Lin XC; Xiang H; Deng XY; Li W; Tang M; Cao Y
Cell Biol Int; 2008 Aug; 32(8):1006-13. PubMed ID: 18579417
[TBL] [Abstract][Full Text] [Related]
17. Dermatopathic lymphadenitis with generalized erythroderma in a patient with epstein-barr virus-associated hemophagocytic lymphohistiocytosis.
Lee WJ; Lee DW; Kim CH; Won CH; Chang SE; Lee MW; Choi JH; Moon KC
Am J Dermatopathol; 2010 Jun; 32(4):357-61. PubMed ID: 20010284
[TBL] [Abstract][Full Text] [Related]
18. Fatal Epstein-Barr virus infection in a case of familial hemophagocytic lymphohistiocytosis with syntaxin-11 mutation.
Albayrak M; Kaya Z; Yilmaz-Keskin E; Stadt UZ; Koçak U; Gürsel T
Turk J Pediatr; 2009; 51(4):371-4. PubMed ID: 19950846
[TBL] [Abstract][Full Text] [Related]
19. Massive expansion of EBV+ monoclonal T cells with CD5 down regulation in EBV-associated haemophagocytic lymphohistiocytosis.
Lin MT; Chang HM; Huang CJ; Chen WL; Lin CY; Lin CY; Chuang SS
J Clin Pathol; 2007 Jan; 60(1):101-3. PubMed ID: 17213357
[TBL] [Abstract][Full Text] [Related]
20. Hematopoietic stem cell transplantation for familial hemophagocytic lymphohistiocytosis and Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in Japan.
Ohga S; Kudo K; Ishii E; Honjo S; Morimoto A; Osugi Y; Sawada A; Inoue M; Tabuchi K; Suzuki N; Ishida Y; Imashuku S; Kato S; Hara T
Pediatr Blood Cancer; 2010 Feb; 54(2):299-306. PubMed ID: 19827139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
